Brigadier General (retired) Dr Richard Tubb, a U.S. citizen, has been appointed a Non-Executive Director of British American Tobacco p.l.c with effect from 28th January 2013.
As one of the longest serving White House physicians, Dr Tubb's leadership spanned more than 14 years and served the Administrations of Presidents Clinton, Bush and Obama. By the time he retired from the White House in 2009, he had served as Director, White House Medical Unit; Physician to the White House; and Physician to the President.
Dr Tubb is a leading public health figure actively involved in the science and policy development of tobacco harm reduction and alternative nicotine products.
Commenting on his appointment, Richard Burrows, Chairman of British American Tobacco p.l.c., said: "I am delighted to be welcoming such a prominent and well respected expert in the field of tobacco harm reduction to our Board. This appointment further demonstrates our commitment to putting science at the heart of our business and I am excited about the role Richard will play in the development of our strategy."
Notes to Editors
About British American Tobacco: British American Tobacco is a global tobacco and Next Generation Product company with brands sold in more than 200 markets. It employs more than 50,000 people worldwide and has over 200 brands in its portfolio, with its cigarettes chosen by one in eight of the world’s one billion smokers. Leading global brands include Dunhill, Kent, Pall Mall and Lucky Strike.
About Next Generation Products (NGP): Next Generation Products is part of the British American Tobacco Group and is focused on developing and delivering high-quality alternative nicotine and tobacco products for adult consumers in the key areas of Vapour, Oral and Tobacco Heating Products. For more information see www.goVype.com and www.bat-science.com.
About Tobacco Harm Reduction: The only way to avoid the risks associated with tobacco use is not to consume tobacco at all, and the best way to reduce the risks is to stop using tobacco. However, the concept of harm reduction is increasingly being considered in relation to tobacco use. Harm reduction is about finding practical ways to minimise the health impact of an inherently risky activity or behaviour, without seeking to stop it entirely. It is a key element of BAT’s business strategy and is being discussed by some regulators. We think it’s important to work towards producing consumer-acceptable, potentially reduced risk products. We believe that tobacco regulatory policies should include harm reduction approaches for the millions of adults globally who will continue to consume tobacco products.
The Public Health Impact of e-cigarettes: Many in the public health community believe e-cigarettes offer great potential for contributing to tobacco harm reduction policies. A 2018 updated evidence review by Public Health England*, an executive body of the UK Department of Health, concludes that vaping is around 95% less harmful than smoking cigarettes. The UK’s Royal College of Physicians have said that the public can be reassured that e-cigarettes are much safer than smoking and that they should be widely promoted as a substitute for smoking.
For more information: email Joanna_Hunt@bat.com or call +44 (0)7858 375461